Incidence, predictors, and relevance of acute kidney injury in patients undergoing left atrial appendage closure with Amplatzer occluders: a multicentre observational study-Reference-Cited by-同舟云学术

Incidence, predictors, and relevance of acute kidney injury in patients undergoing left atrial appendage closure with Amplatzer occluders: a multicentre observational study

Published:2019-07-05 Issue:4 Volume:109 Page:444-453
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Sedaghat Alexander^ORCID,Vij Vivian,Streit Samuel R.,Schrickel Jan Wilko,Al-Kassou Baravan,Nelles Dominik,Kleinecke Caroline,Windecker Stephan,Meier Bernhard,Valglimigli Marco,Nietlispach Fabian,Nickenig Georg,Gloekler Steffen

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-019-01524-9.pdf

Reference30 articles.

1. Reddy VY, Holmes D, Doshi SK et al (2011) Safety of percutaneous left atrial appendage closure: results from the watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation 123:417–424. https://doi.org/10.1161/CIRCULATIONAHA.110.976449

2. Tzikas A, Shakir S, Gafoor S et al (2016) Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention 11:1170–1179. https://doi.org/10.4244/EIJY15M01

3. Holmes DR, Kar S, Price MJ et al (2014) Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 64:1–12. https://doi.org/10.1016/j.jacc.2014.04.029

4. D’Ancona G, Safak E, Ince H (2019) Left atrial appendage occlusion in patients with atrial fibrillation and high risk of fall: a clinical dilemma or a budgetary issue? Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01476-0

5. Seeger J, Bothner C, Dahme T et al (2016) Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Clin Res Cardiol 105:225–229. https://doi.org/10.1007/s00392-015-0910-8

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contrast-free left atrial appendage occlusion in patients using the LAMBRE™ device;International Journal of Cardiology;2024-06

2. Zero-contrast left atrial appendage closure, a feasible alternative for patients with a high risk of contrast-induced nephropathy: Systematic literature review and meta-analysis;Heart Rhythm;2024-05

3. Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis;Clinical Research in Cardiology;2023-12-19

4. Efficacy and safety of patients with chronic kidney disease undergoing left atrial appendage closure for atrial fibrillation;PLOS ONE;2023-10-26

5. Zero-Contrast Percutaneous Left Atrial Appendage Occlusion With WATCHMAN FLX Device;JACC: Clinical Electrophysiology;2023-07